ArticleBreast cancer research and treatment2021

Myosteatosis at diagnosis is adversely associated with 2-year survival in women with estrogen receptor-negative metastatic breast cancer.

Patricia Sheean et al.PubMed ↗Publisher ↗

No numbers read from the abstract.